Asymmetric synthesis of 2,3-disubstituted oxepanes via acetalization–cyclization of an enantioenriched functionalized allylsilane with aldehydes

(Note: The full text of this document is currently only available in the PDF Version )

Michinori Suginome, Taisuke Iwanami and Yoshihiko Ito


Abstract

According to the protocol for the acetalization–intramolecular allylsilane cyclization, a new enantioenriched allylsilane, (R)-(E)-7-(dimethylphenylsilyl)undec-5-en-1-ol, in the presence of a variety of aldehydes provided enantioenriched trans-2,3-disubstituted oxepanes stereoselectively.


References

  1. For the five-membered ring formation, see: P. Mohr, Tetrahedron Lett., 1993, 34, 6251 Search PubMed; T. Oriyama, A. Ishiwata, T. Sano, T. Matsuda, M. Takahashi and K. Koga, Tetrahedron Lett., 1995, 36, 5581 CrossRef CAS; T. Sano and T. Oriyama, Synlett, 1997, 716 CrossRef CAS.
  2. For the six-membered ring formation, see: I. E. Markó and A. Mekhalfia, Tetrahedron Lett., 1992, 33, 1799 Search PubMed; I. E. Markó and D. J. Bayston, Tetrahedron, 1994, 50, 7141 CrossRef CAS; I. E. Markó, M. Bailey, F. Murphy, J. P. Declercq, B. Tinant, J. Feneau-Dupont, A. Krief and W. Dumont, Synlett, 1995, 123 CrossRef CAS.
  3. M. Suginome, T. Iwanami and Y. Ito, J. Org. Chem., 1998, 63, 6096 CrossRef CAS.
  4. For a review of the reactions of chiral allylsilanes, see: C. E. Masse and J. S. Panek, Chem. Rev., 1995, 95, 1293 Search PubMed.
  5. K. Matsumura, S. Hashiguchi, T. Ikariya and R. Noyori, J. Am. Chem. Soc., 1997, 119, 8738 CrossRef CAS; K.-J. Haack, S. Hashiguchi, A. Fujii, T. Ikariya and R. Noyori, Angew. Chem., Int. Ed. Engl., 1997, 36, 285 CrossRef CAS The absolute configuration (S) of 3 was assigned by an analogy with these reports.
  6. M. Suginome, A. Matsumoto and Y. Ito, J. Am. Chem. Soc., 1996, 118, 3061 CrossRef CAS; M. Suginome, T. Iwanami, A. Matsumoto and Y. Ito, Tetrahedron: Asymmetry, 1997, 8, 859 CrossRef CAS.
  7. The absolute configuration (R) was assigned by analogy with previous reports. See ref. 5 and 6. Selected data for (R)-1: δH(CDCl3) 0.24 (s, 3H), 0.25 (s, 3H), 0.82 (t, J 6.9, 3H), 1.04–1.68 (m, 13H), 1.97–2.05 (m, 2H), 3.62 (t, J 6.6, 2H), 5.10–5.25 (m, 2H), 7.31–7.37 (m, 3H), 7.43–7.51 (m, 2H); δC(CDCl3)–5.1, –4.5, 13.9, 22.3, 26.0, 28.5, 31.4, 32.4, 32.5, 62.9, 127.6, 128.5, 128.8, 131.5, 134.1, 138.4; νmax(neat)/cm–1 3356, 2968, 2940, 2864, 1432, 1250, 1114 (calc. for C19H32OSi 304.2222, found 304.2221); [α]20D–8.38 (c 3.1, benzene).
  8. The trans stereochemistry in the seven-membered ring was determined on the basis of the 1H NMR coupling constant between the 2- and 3-protons in the ring. Compound 6a exhibited a coupling constant of 9.6 Hz, whereas that for trans- and cis-2-(phenylsulfonylmethyl)-3-(phenylmethyl)oxepane were reported as 8.5 and 2.6 Hz, respectively. See: P. L. López-Tudanca, K. Jones and P. Brownbridge, Tetrahedron Lett., 1991, 32, 2261 Search PubMed.
  9. The enantiomeric excesses of 6, except for 6a, were determined after derivatization to the corresponding 2-substituted 3-oxepanecarboxylic acid by RuO2-catalyzed oxidative C = C bond cleavage in the presence of NaIO4(CCl4, MeCN, H2O). The 3,5-dinitrophenylanilides were subjected to chiral HPLC with Sumichiral OA columns indicated below [compound, column, solvent (a ratio of hexanes–1,2-dichloroethane–ethanol)]: (6b, OA-4400, 50∶15∶1); (6c, OA-4500 × 3, 15∶15∶1); (6d, OA-4400, 15∶5∶1); (6e, OA-4900, 15∶5∶1); (6f, OA-4500, 15∶5∶1); (6g, OA-4600, 15∶5∶1). The absolute configurations were assigned by analogy with the stereochemical outcome for the six-membered ring formation reported previously. See ref. 3.
  10. The slight decrease in the enantiomeric excesses may be attributed to a minor contribution ‘syn attack’ of the electrophiles on the allylsilane moieties during the cyclization in addition to the normal ‘anti attack’. For a discussion on the ‘antivs.syn’ attack in the reaction of allylsilanes with electrohiles, see: M. J. C. Bucke, I. Fleming and S. Gil, Tetrahedron Lett., 1992, 33, 4479 Search PubMed.
Click here to see how this site uses Cookies. View our privacy policy here.